The company is a full-service scientific consulting firm, specialized in solving complex regulatory and compliance issues. The company provides a variety of services, including Food and Drug Administration (FDA) enforcement support, quality system remediation support, auditing, regulatory strategy, and strategic consulting.

Key Aspects

From 2019 to 2022, revenue and adjusted EBITDA grew at compound annual growth rates of 54.0% and 92.4%, respectively
Adjusted EBITDA margins averaged 32.9% from 2019 through 2022

Growing pipeline of signed contracts driving revenue in 2023

Diverse client base in high-growth industries, with management noting a reoccurring client rate of 87%
Lean operating model, with six W2 employees and an expert consultant network of over 200 individuals, with an average 25 years of experience in their respective fields

Opportunities

Capitalize on the recent addition of executive-level personnel, enabling the company to take on a greater number of projects
Implement a strategic marketing campaign to generate new business, beyond receiving just word-of-mouth referrals, based on the company’s proven client satisfaction record
Expand the company’s service offerings and capabilities for clients in the high-growth biologics industry, specifically for cell and gene therapy
Strategically expand the company’s expert consultant network to include other regulatory areas the company is not yet involved in

Headquartered

United States

Current Markets

The company serves a variety of businesses, with a focus on the pharmaceutical, biologics, and medical device industries. The company’s clients are primarily US-based (95%) with the remaining located across the globe.

Real Estate

The company operates fully remote with no physical location being leased or owned.

Shareholder Objectives

The company is fully owned by a single shareholder who would like to financially de-risk and pursue personal endeavors. The owner is willing to remain with the company for a predetermined amount of time to facilitate a smooth transition of ownership.

Benchmark International

Benchmarks Exclusive Opportunities

Scientific Consulting Firm Specialized in Regulatory and Compliance Issues – BN000046803

Scientific Consulting Firm Specialized in Regulatory and Compliance Issues – BN000046803

Login